Adoption of Pneumococcal Vaccines Market to Surge During the Forecast Period Owing to Increased Consumer Demand by 2028 | FMI
Future Market Insights (FMI) offers a 10-year forecast on the global pneumococcal vaccines market. The primary objective of the report is to offer updates and information related to opportunities in the global pneumococcal vaccines market.
In terms of revenue, the global pneumococcal vaccines market is expected to register a CAGR of 9.1% during the forecast period of 2018–2028. The primary objective of the report is to offer insights on the market dynamics that can influence the growth of the global pneumococcal vaccines market over the forecast period. Insights on the key trends, drivers, restraints, value forecasts and opportunities for companies operating in the global pneumococcal vaccines market are presented in the report.
The global demand for pneumococcal vaccines is increasing as a result of the large burden of pneumonia-related child mortality rate. Pneumonia is the leading cause of child deaths. 16% of all deaths under age 5 are due to pneumonia. The governments across the globe are focusing on reducing the mortality rate with the help of pneumococcal immunization, which is expected to fuel the growth of the pneumococcal vaccines market.
Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7078
Besides, the support from Gavi to low-income countries for pneumococcal immunization is expected to boost the growth of the pneumococcal vaccines market. Availability of cost-effective vaccines in developing countries as well as favourable reimbursement policies for pneumococcal conjugate and polysaccharide vaccine are expected to spur the demand for pneumococcal vaccines.
Research & development activities for the development of new pneumococcal vaccines, balanced supply and demand, government and private funding for pneumococcal vaccines are expected to boost the demand for pneumococcal vaccines over the forecast period. Manufacturers are focusing on mergers and collaborations for the development of new vaccines, whereas increasing pharmacy-based pneumococcal immunization is expected to create huge opportunities for growth of the pneumococcal vaccines market.
The revenue of the pneumococcal vaccines market in North America is expected to grow at the high rate. To understand and assess opportunities in this market, the report offers the market forecast on the basis of product type and distribution channel. The report provides analysis of the global pneumococcal vaccines market in terms of market value (US$ Mn).
The report begins with the market definition, followed by definitions of the different pneumococcal vaccines types. The market dynamics section includes FMI’s analysis on key trends, drivers, restraints, opportunities and macro-economic factors influencing the growth of the global pneumococcal vaccines market. Opportunity analysis provided in the section allows clients to better equip with crystal clear decision-making insights
The subsequent section of the report provides analysis of the market on the basis of regions and presents forecast in terms of value for the next 10 years. The regions covered in the report include:
- North America
- Latin America
- Rest of Latin America
- Western Europe
- Rest of Western Europe
- Eastern Europe
- Rest of Eastern Europe
- Asia Pacific Excluding Japan
- Australia & New Zealand
- Rest of APEJ
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
The next section provides competitive edge of the global pneumococcal vaccines market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the pneumococcal vaccines market. The competition landscape section provides dashboard view of the activities of major players in the global pneumococcal vaccines market. The company profiles section provides information on the key offerings of each player in the global pneumococcal vaccines market, their direct & indirect presence, revenue, key developments and strategies and SWOT analysis. The key players included in this report are Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc., Merck & Co., Inc.
The next section analyses the market on the basis of product type and presents the forecast in terms of value (US$ Mn) for the next 10 years. The product types covered in the report include:
- Pneumococcal Polysaccharide Vaccines
- Pneumococcal Conjugate Vaccines
The next section analyses the market on the basis of the distribution channel and presents forecast in terms of value (US$ Mn) for the next 10 years. The distribution channels covered in the report include:
- Community Clinics
- Public Health Agencies
In addition, we have considered Year-on-Year (Y-o-Y) growth to understand the predictability of the market and identify growth opportunities for companies operating in the global pneumococcal vaccines market.
Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-7078
Another key feature of this report is the analysis of the key segments in terms of absolute dollar opportunity. This is usually overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered by pneumococcal vaccines market. To understand the key segments in terms of their growth and performance in the global pneumococcal vaccines market, Future Market Insights has developed a market attractiveness index. The resulting index will help providers to identify the existing market opportunities.
Explore Wide-ranging Coverage of FMI’s Healthcare Landscape
Respiratory Inhaler Devices Market – A slew of new drugs were launched for the management of asthma and COPD over the last decade and development of more are currently underway. With leading drug manufacturers expecting the demand to surge amid COVID-19, respiratory inhaler sales are set to grow steadily through 2030.
Microbial Therapeutic Products Market – The global microbial therapeutic products market is poised to expand robustly at a value CAGR worth 7% across the 2020-2030 assessment period. Rising prevalence of lifestyle induced chronic disorders as well as antimicrobial resistance are primarily driving the market’s growth.
Transradial Closure Devices Market – According to Future Market Insights (FMI), the demand from hospitals, independent catheterization centers, and healthcare clinics will continue rising. Spurred by this, the global transradial closure devices market is set to grow by 6.5% CAGR during the forecast period from the year 2020 to 2030.
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: email@example.com
For Media Enquiries: firstname.lastname@example.org